Background Portal vein thrombosis (PVT) may be associated with negative outcomes in
patients with liver cirrhosis. However, the prevalence and incidence of PVT in liver cirrhosis …

Portal vein thrombosis constitutes the most common thrombotic event in patients with
cirrhosis, with increased rates in the setting of advanced liver disease. Despite being a well …

Methods This document presents the official recommendations of the American
Gastroenterological Association Institute (AGA) on the management of coagulation disorders …

Background & Aims Previous meta-analyses demonstrated the safety and efficacy of
anticoagulation in the recanalization of portal vein thrombosis in patients with cirrhosis …

Much has evolved over the past 25 years regarding the coagulopathy of liver disease.
Paradoxically, this form of coagulopathy is relatively hypercoagulable despite the common …

Although patients with cirrhosis are known to be in a state of “rebalance” in that pro-and
anticoagulant factors increase the risk for both bleeding and thrombosis, the prevalence of …

Objective To evaluate the efficacy and safety of anticoagulant therapy in patients with
cirrhotic PVT, and compare differences in efficacy and safety among different anticoagulants …

Introduction Liver cirrhosis is accompanied by several hemostatic alterations, which
contribute to the current theory of “rebalanced hemostasis.” Splanchnic vein thrombosis …

The clinical utility of anticoagulation for patients with cirrhosis and asymptomatic portal vein
thrombosis (PVT) is widely debated. Complex hemostatic derangements in cirrhosis that …

Aim: The purpose of our study was to conduct a retrospective analysis to compare the
effectiveness of transjugular intrahepatic portosystemic shunts (TIPSs) in the treatment of …